Up to date: Jan 18, 2021 04:03 IST
Brasilia [Brazil], January 18 (ANI/Sputnik): The Brazilian Well being Regulatory Company (Anvisa) on Sunday accepted using two vaccines towards the coronavirus illness, developed by firms AstraZeneca and Sinovac.
The choice is claimed to have been made on the regulator’s assembly.
The specialists famous the security and effectiveness of these vaccines and requested the businesses to proceed offering data to Anvisa.
Earlier, the regulator refused to grant Brazilian pharmaceutical firm Uniao Quimica authorization for the emergency use of Russia’s Sputnik V vaccine. (ANI/Sputnik)